Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Manuel Herrero-Montes has a total of 95 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effectiveness of K-cards on Clinical Outcomes: A Systematic Review of Their Application in the Hospital Setting

    by Andrea M. Aceros-Lora, Manuel Herrero-Montes, Angie Yarlady Serrano-Garcia, Lyda Z. Rojas

    Introduction: Kamishibai cards (K-cards) are a visual management and audit tool used in hospitals to reinforce standard work and patient-safety bundles. Objectives: To synthesize the evidence on the effectiveness of K-cards on clinical outcomes in hospital settings. Methodology: Searches were performed in the Medline-PubMed, EMBASE, EBSCO-Host, Web of Science, Google Scholar, and Lilacs databases from inception to February 15, 2024, using the free terms “Kamishibai cards” and “K-card”, without language restrictions. Four reviewers screened titles/abstracts in pairs; full texts were assessed by two independent reviewers. Meta-analysis was not feasible due to heterogeneity. Results: Twelve studies were included. Outcomes varied and included catheter-associated infections, bundle compliance, hypothermia, sleep-related measures, and professional practice. One study reported a significant increase in bundle compliance from 43% to 78% at 12 months after implementation. Conclusions: K-cards may simplify processes, support audits, enhance peer feedback, and help reduce adverse events in adult and pediatric hospital settings. However, implementation strategies are heterogeneous and the evidence is predominantly quasi-experimental, limiting generalizability. Keywords: health care; k‐card; patient safety; quality improvement; hospital; nursing

  • Open Access

    Nursing insights into the management of procedural pain in pediatric patients: A qualitative study

    by Laura Ruiz-Azcona, Manuel Herrero-Montes, Sonia Mateo-Sota, Carolina Lechosa-Muñiz, Domingo Palacios-Ceña, Paula Parás-Bravo

  • Open Access

    Global Economic and Social Burden of Chronic Obstructive Pulmonary Disease: A Systematic Review (2020–2024)

    by Celia Gutiérrez-Villegas, Manuel Herrero-Montes, Luis Manuel Fernández Cacho, Carlos Antonio Amado-Diago, Valentín Perales-García, Andrea Marcela Aceros Lora, María Paz-Zulueta

    Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide and imposes a substantial economic and social burden on healthcare systems and society. Objective: To analyse recent evidence (2020– 2024) on the economic and social burden of COPD, including direct, indirect, and intangible costs. Methods: A systematic review was conducted to synthesise recent evidence on the economic and social burden of COPD published between January 2020 and December 2024. Searches were performed in PubMed/MEDLINE, Scopus, and Web of Science. Original studies reporting direct healthcare costs, direct non-healthcare costs, indirect costs or intangible costs related to health-related quality of life (HRQoL) were included. Results: Thirty studies from 15 countries were included. Direct healthcare costs represent the main component of expenditure, largely driven by hospitalisations and exacerbations. Annual costs ranged from € 3500 to € 10,000 per patient in Europe and from US$10,000 to US$17,000 in the United States. Although absolute costs were lower in Asia, the relative financial burden on patients was considerable. Direct non-healthcare costs, including out-of-pocket expenses and long-term care, were particularly relevant in severe disease. Indirect costs related to productivity losses and unemployment were substantial and, in some middle-income countries, exceeded healthcare costs. Intangible costs included anxiety, depression, caregiver distress, impaired quality of life, and perceived financial toxicity, with high overall prevalence. Conclusion: COPD creates a considerable economic and social burden. Although direct costs are predominant, indirect, and intangible costs are decisive, particularly in contexts with lower healthcare coverage. Clinical factors (severity, exacerbations, and comorbidities) and socio-economic factors (educational level, income, and employment) explain much of the variability. A holistic approach that addresses health, social, and emotional dimensions is required for a more equitable and sustainable management.

  • Open Access

    Childbirth in Women Infected or in Close Contact With SARS ‐ CoV ‐2 in Spain: A Qualitative Study

    by Paula Parás‐Bravo, Domingo Palacios‐Ceña, Paloma Moro‐López‐Menchero, Manuel Herrero‐Montes, Cesar Fernandez‐De‐Las‐Peñas, Maria Jesus Cabero, Carolina Lechosa‐Muñiz

    Objective: To explore the perinatal and birth experiences of pregnant women infected, or in close contact with SARS‐CoV‐2 during the first wave of the pandemic in a hospital in northern Spain. Methods: A qualitative descriptive study was conducted. The Standards for Reporting Qualitative Research and the Consolidated Criteria for Reporting Qualitative Research were followed. Purposeful and non‐probabilistic sampling were used. Recruitment started in December 2022 and continued until February 2023. The inclusion criteria consisted of: (a) Women > 18 years old fluent in Spanish, (b) pregnant women infected with or in close contact with SARS‐CoV‐2 at the time of delivery, and (c) those who gave birth at HUMV during the first wave of COVID‐19 (March–June 2020). In‐depth interviews and researcher field notes were used for data collection. A thematic inductive analysis was performed. Results: Nineteen participants were included. The mean age of participants was 34.94 years (standard deviation, SD: 4.17). Five themes emerged: (a) Uncertainty about COVID‐19; (b) Loss of control of the situation; (c) Loss of normality; (d) Impact of restrictions on neonatal care and (e) Unexpected positive experiences. Conclusions: Participants infected or in isolation due to close contact with SARS‐CoV2 who became mothers during the COVID‐19 pandemic experienced the perinatal process and particularly childbirth as a traumatic event. Loss of control of the situation and separation from the partner and the baby were experienced with anguish, confusion, and uncertainty. This experience had a lasting emotional impact over time. Clinical Implications: In the future, respecting the woman's decisions in relation to childbirth, humanizing care throughout the process, not separating the mother from the baby except in extreme circumstances, and treating the couple as an inseparable and essential element during pregnancy, childbirth, and postpartum processes could help reduce trauma for people giving birth during pandemics.

  • Open Access

    Serological Biomarkers in Individuals with Interstitial Lung Disease after SARS-CoV-2 Infection and Association with Post-COVID-19 Symptoms

    by Paula Parás-Bravo, César Fernández-De-Las-Peñas, Diego Ferrer-Pargada, Sheila Izquierdo-Cuervo, Luis M. Fernández-Cacho, José M. Cifrián-Martínez, Patricia Druet-Toquero, Oscar Pellicer-Valero, Manuel Herrero-Montes

    Patients with interstitial lung disease (ILD) represent a vulnerable population against an acute SARS-CoV-2 infection. It has been observed that up to 80% of patients with ILD can develop post-COVID-19 symptomatology one year after. This secondary analysis aimed to, 1, compare serological biomarkers before and after surpassing a SARS-CoV-2 infection in individuals with interstitial lung disease (ILD) and, 2, to compare serological biomarkers between ILD patients who develop and those who do not develop post-COVID-19 symptoms. Seventy-six patients with ILD (40.4% women, age: 69, SD: 10.5 years) who survived a SARS-CoV-2 infection participated. High-resolution computerized tomography (CT) of the lungs, two pulmonary function tests (forced vital capacity (FVC) and diffusion value of carbon monoxide (DLCO)) and fourteen serological biomarkers were collected before and after SARS-CoV-2 infection. Participants were asked for the presence of post-COVID-19 symptomatology a mean of twelve (SD: eight) months after infection. Sixty patients (79%) showed post-COVID-19 symptoms (mean: 3.5, SD 1.1), with fatigue (68.4%), dyspnea (31.5%), and concentration loss (27.6%) being the most prevalent. Creatine phosphokinase (CPK) was the only biomarker showing differences in our study. In fact, CPK levels were higher after the acute SARS-CoV-2 infection (mean difference: 41.0, 95%CI 10.1 to 71.8, p = 0.03) when compared to before the infection. Thus, CPK levels were also higher in ILD patients with post-COVID-19 fatigue (mean difference: 69.7, 95%CI 12.7 to 126.7, p = 0.015) or with post-COVID-19 dyspnea (mean difference: 34.8, 95%CI 5.2 to 64.4, p = 0.025) than those patients without these post-COVID-19 symptoms. No significant changes in CT or functional pulmonary tests were observed after COVID-19 in patients with ILD. In conclusion, patients with ILD exhibited an increase in CPK levels after SARS-CoV-2 infection, albeit no changes in other serological biomarkers were identified. Similarly, the presence of post-COVID-19 fatigue or dyspnea was also associated with higher CPK levels in ILD patients. Studies investigating long COVID mechanisms in vulnerable populations such as ILD are needed.


  • Evaluating Sensitization-associated, Neuropathic-like Symptoms and Psychological Factors in Patients With Interstitial Lung Disease

    by Paula Parás-Bravo, César Fernández-De-Las-Peñas, Diego Ferrer-Pargada, Patricia Druet-Toquero, Luis M. Fernández-Cacho, José M. Cifrián-Martínez, Lars Arendt-Nielsen, Manuel Herrero-Montes


  • Prevalence of post-COVID symptoms one-year after SARS-CoV-2 infection in patients with interstitial lung disease

    by Paula Parás-Bravo, César Fernández-De-Las-Peñas, Diego Ferrer-Pargada, Sheila Izquierdo-Cuervo, Manuel Herrero-Montes


  • Open Access

    Coping with the hospital environment during the COVID-19 pandemic: A qualitative study of the survivors' perspective during their stay at the ICU and inpatient ward

    by Manuel Herrero-Montes, Paula Parás-Bravo, Diego Ferrer-Pargada, César Fernández-De-Las-Peñas, Luis Manuel Fernández-Cacho, Domingo Palacios-Ceña


  • Open Access

    Surgical vs. transcatheter arotic valve replacement in patients over 75 years with aortic stenosis: sociodemographic profile, clinical characteristics, quality of life and functionality

    by Víctor Fradejas-Sastre, Paula Parás-Bravo, Manuel Herrero-Montes, María Paz-Zulueta, Ester Boixadera-Planas, Luis Manuel Fernández-Cacho, Gabriela Veiga-Fernández, Maria Elena Arnáiz-García, Jose María De-La-Torre-Hernández

    Background: Aortic valve stenosis (AVS) affects 25% of the population over 65 years. At present, there is no curative medical treatment for AVS and therefore the surgical approach, consisting of transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR), is the treatment of choice. Methodology: The aim of this study was to analyze the sociodemographic and clinical characteristics, quality of life and functionality of a sample of patients with AVS over 75 years of age, who underwent TAVR or SAVR, applying standard clinical practice. A prospective multicenter observational study was conducted in two hospitals of the Spanish National Health System. Data were collected at baseline, 1, 6 months and 1 year. Results: In total, 227 participants were included, with a mean age of 80.6 [SD 4.1]. Statistically significant differences were found in terms of quality of life, which was higher at 1 year in patients who underwent SAVR. In terms of functionality, SAVR patients obtained a better score (p < 0.01). However, patients who underwent TAVR began with a worse baseline situation and managed to increase their quality of life and functionality after 1 year of follow-up. Conclusion: The individualized choice of TAVR or SAVR in patients with AVS improves patients’ quality of life and function. Moreover, the TAVR procedure in patients with a worse baseline situation and a high surgical risk achieved a similar increase in quality of life and functionality compared to patients undergoing SAVR with a better baseline situation.


  • Open Access

    Association of Kinesiophobia with Catastrophism and Sensitization-Associated Symptoms in COVID-19 Survivors with Post-COVID Pain

    by Manuel Herrero-Montes, César Fernández-De-Las-Peñas, Diego Ferrer-Pargada, Sheila Izquierdo-Cuervo, Beatriz Abascal-Bolado, Juan Antonio Valera-Calero, Paula Paras-Bravo

    Pain symptoms after the acute phase of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are present in almost 50% of COVID-19 survivors. The presence of kinesiophobia is a risk factor which may promote and perpetuate pain. This study aimed to investigate variables associated with the presence of kinesiophobia in a sample of previously hospitalized COVID-19 survivors exhibiting post-COVID pain. An observational study was conducted in three urban hospitals in Spain, including one hundred and forty-six COVID-19 survivors with post-COVID pain. Demographic (age, weight, height), clinical (intensity and duration of pain), psychological (anxiety level, depressive level, sleep quality), cognitive (catastrophizing), sensitization-associated symptoms, and health-related quality of life variables were collected in 146 survivors with post-COVID pain, as well as whether they exhibited kinesiophobia. Stepwise multiple linear regression models were conducted to identify variables significantly associated with kinesiophobia. Patients were assessed a mean of 18.8 (SD 1.8) months after hospital discharge. Kinesiophobia levels were positively associated with anxiety levels (r: 0.356, p < 0.001), depression levels (r: 0.306, p < 0.001), sleep quality (r: 0.288, p < 0.001), catastrophism (r: 0.578, p < 0.001), and sensitization-associated symptoms (r: 0.450, p < 0.001). The stepwise regression analysis revealed that 38.1% of kinesiophobia variance was explained by catastrophism (r2 adj: 0.329, B = 0.416, t = 8.377, p < 0.001) and sensitization-associated symptoms (r2 adj: 0.381, B = 0.130, t = 3.585, p < 0.001). Kinesiophobia levels were associated with catastrophism and sensitization-associated symptoms in previously hospitalized COVID-19 survivors with post-COVID pain. Identification of patients at a higher risk of developing a higher level of kinesiophobia, associated with post-COVID pain symptoms, could lead to better therapeutic strategies.